Renal Dysfunction After Living-Donor Liver Transplantation: Experience with 500 Cases
Overview
Authors
Affiliations
The possible risk factors for chronic kidney disease in transplant recipients have not been thoroughly investigated after living-donor liver transplantation. A retrospective cohort study of consecutive adults who underwent living-donor liver transplantation between May 2004 and October 2016, in a single center, was conducted. Kidney function was investigated successively for all the patients throughout the study period, with 12 months being the shortest follow-up. Postoperative renal dysfunction was defined in accordance with the Chronic Kidney Disease Epidemiology Collaboration criteria. The patients' demographic data, preoperative and intraoperative parameters, and outcomes were recorded. A calcineurin inhibitor-based immunosuppressive regimen, either tacrolimus or cyclosporine, was used in all the patients. Of the 413 patients included in the study, 33 (8%) who survived for ≥1 year experienced chronic kidney disease 1 year after living-donor liver transplantation. Twenty-seven variables were studied to compare between the patients with normal kidney functions and those who developed chronic kidney disease 1 year after living-donor liver transplantation. Univariate regression analysis for predicting the likelihood of chronic kidney disease at 1 year revealed that the following 4 variables were significant: operative time, < 0.0005; intraoperative blood loss, < 0.0005; preoperative renal impairment, = 0.001; and graft-to-recipient weight ratio (as a negative predictor), < 0.0005. In the multivariate regression analysis, only 2 variables remained as independent predictors of chronic kidney disease at 1 year, namely, operative time with a cutoff value of ≥714 minutes and graft-to-recipient weight ratio as a negative predictor with a cutoff value of <0.91. In this study, prolonged operative time and small graft-to-recipient weight ratio were independent predictors of chronic kidney disease at 1 year after living-donor liver transplantation.
Demiroz D, Colak Y, Ozdes O, Ucar M, Erdogan M, Toprak H Indian J Crit Care Med. 2024; 28(1):75-79.
PMID: 38510757 PMC: 10949289. DOI: 10.5005/jp-journals-10071-24616.
Park J, Kim S, Choi H, Hong S, Chae M J Clin Med. 2022; 11(2).
PMID: 35054144 PMC: 8779454. DOI: 10.3390/jcm11020450.
Park J, Joo M, Choi H, Hong S, Park C, Choi J PLoS One. 2021; 16(6):e0252715.
PMID: 34086798 PMC: 8177619. DOI: 10.1371/journal.pone.0252715.
Kidney Function After Liver Transplantation in a Single Center.
Niewinski G, Smyk W, Graczynska A, Kostrzewa K, Raszeja-Wyszomirska J, Oldakowska-Jedynak U Ann Transplant. 2021; 26:e926928.
PMID: 33619240 PMC: 7911851. DOI: 10.12659/AOT.926928.
Muta K, Kitamura M, Hidaka M, Ota Y, Hara T, Soyama A Ann Transplant. 2021; 26:e928858.
PMID: 33558451 PMC: 7883405. DOI: 10.12659/AOT.928858.